Author

Mark D. Anderson

OpenAlex ID: A5153841123

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial

2026 · Patrick Y. Wen, Donald A. Berry, et al. · Journal of Clinical Oncology · 12

Works count: 1

Citation count: 11

H-index: 1

I10-index: 1